AI Fertility Innovator ONTO Health Secures $20M Series A

ONTO Health, a physician-led innovator in AI-powered fertility and longevity solutions, has successfully closed a $20 million Series A funding round. The investment was led by prominent healthcare investors ARTIS and Humania, signaling strong confidence in ONTO's integrated approach to reproductive and lifelong wellness.

The newly acquired capital is earmarked for significant expansion initiatives. ONTO plans to broaden its advanced fertility care services across the United States and establish a strategic presence in the Gulf Cooperation Council (GCC) region. This expansion aims to make sophisticated, AI-enhanced reproductive health services more accessible to a wider patient demographic.

Founded by Dr. Roohi Jeelani, a specialist in Reproductive Endocrinology and Infertility, ONTO Health distinguishes itself by viewing fertility as a critical component of overall, long-term health. The company's proprietary platform leverages artificial intelligence to enhance diagnostic accuracy, automate clinical workflows, and personalize treatment plans, thereby improving patient outcomes and streamlining the care journey. This holistic model moves beyond episodic treatment to encompass a continuous health trajectory.

The fertility market, a segment within the broader women's health sector, is experiencing substantial growth, driven by factors such as delayed childbearing and advancements in assisted reproductive technologies. The global fertility services market was valued at approximately $15 billion in 2023 and is projected to grow at a CAGR of over 10% in the coming years. ONTO Health's AI-driven approach is well-positioned to capture a significant share of this expanding market by offering more efficient and effective care.

Stuart Peterson, CEO and Managing Partner of ARTIS, highlighted the company's innovative model, stating, "Dr. Jeelani has already demonstrated that fertility care can be proactive, integrated, and scalable without losing sight of the human experience." He further emphasized ONTO's capacity to extend high-quality reproductive care across diverse geographies.

Makarem S. Batterjee, Vice Chairman of Saudi German Group and Founder & President of Humania, expressed enthusiasm for the partnership, noting, "The integration of AI and automation into fertility care represents a transformative leap, enhancing diagnostics, personalization, and outcomes while making high-quality treatment more accessible for families across the region." Humania's extensive network of hospitals and outpatient facilities in the Gulf and North Africa will be instrumental in ONTO's regional rollout.

Aamir Rehan, CEO of Humania, added that ONTO exemplifies the type of U.S.-based leader in AI and automation that their partnership with ARTIS seeks to identify and scale into key international markets. The collaboration aims to bring cutting-edge healthcare innovations to regions with accelerating demand for world-class medical services.